Kidney Cancer Archives - Page 66 of 66 - Renal and Urology News

Kidney Cancer

Drugs Aid Metastatic RCC Outcomes

Two relatively new oral agents can improve outcomes for patients with metastatic renal cell carcinoma (RCC), according to recent reports. The drugs, sunitinib and sorafenib, inhibit enzymes that promote angiogenesis and thus may act by disrupting tumor vasculature.

Sorafenib Outcomes Unaffected by Age

ISTANBUL—Age does not affect clinical outcomes in sorafenib-treated patients with advanced renal cell carcinoma (RCC), researchers announced here at the 31st congress of the European Society for Medical Oncology.

CRP Predicts Worse RCC Survival

High preoperative C-reactive protein (CRP) levels are associated with worse survival in patients who undergo radical nephrectomy for localized renal cell carcinoma (RCC), according to investigators.

Expectant Management A Viable Option

ATLANTA—Delayed intervention for treating small renal masses may be appropriate for selected patients, especially those with competing comorbidities, a study found. This conservative approach has little adverse effect on pathological and clinical outcomes, researchers note.

Next post in News